ACS Infectious Diseases, volume 4, issue 5, pages 715-735

Developments in Glycopeptide Antibiotics

Blaskovich Mark AT ^{1, 2}

Hansford Karl A ^{1, 2}

Butler Mark D. ^{1, 2}

Jia Zhiguang ^{1, 2}

Mark Alan E. ^{1, 2}

Cooper Matthew A. ^{1, 2}

Hide authors affiliations Show authors affiliations: 2 affiliations

Institute for Molecular Bioscience, The University of Queensland, 306 Carmody Road, Brisbane, Queensland 4072, Australia |

School of Chemistry and Molecular Biosciences, The University of Queensland, Chemistry Building 68, Cooper Road, Brisbane, Queensland 4072, Australia |

Publication type: Journal Article

Publication date: 2018-01-24

American Chemical Society (ACS)

Journal: ACS Infectious Diseases

Quartile SCImago

Quartile WOS

Impact factor: 5.3

ISSN: 23738227

DOI: 10.1021/acsinfecdis.7b00258

Copy DOI

PubMed ID: 29363950

Infectious Diseases

Abstract

Glycopeptide antibiotics (GPAs) are a key weapon in the fight against drug resistant bacteria, with vancomycin still a mainstream therapy against serious Gram-positive infections more than 50 years after it was first introduced. New, more potent semisynthetic derivatives that have entered the clinic, such as dalbavancin and oritavancin, have superior pharmacokinetic and target engagement profiles that enable successful treatment of vancomycin-resistant infections. In the face of resistance development, with multidrug resistant (MDR) S. pneumoniae and methicillin-resistant Staphylococcus aureus (MRSA) together causing 20-fold more infections than all MDR Gram-negative infections combined, further improvements are desirable to ensure the Gram-positive armamentarium is adequately maintained for future generations. A range of modified glycopeptides has been generated in the past decade via total syntheses, semisynthetic modifications of natural products, or biological engineering. Several of these have undergone extensive characterization with demonstrated in vivo efficacy, good PK/PD profiles, and no reported preclinical toxicity; some may be suitable for formal preclinical development. The natural product monobactam, cephalosporin, and β-lactam antibiotics all spawned multiple generations of commercially and clinically successful semisynthetic derivatives. Similarly, next-generation glycopeptides are now technically well positioned to advance to the clinic, if sufficient funding and market support returns to antibiotic development.

By date By citations

Citations by journals

	1 2 3 4 5 6 7 8
ACS Infectious Diseases	ACS Infectious Diseases, 8, 4.49% ACS Infectious Diseases 8 publications, 4.49%
Journal of Medicinal Chemistry	Journal of Medicinal Chemistry, 7, 3.93% Journal of Medicinal Chemistry 7 publications, 3.93%
Antibiotics	Antibiotics, 6, 3.37% Antibiotics 6 publications, 3.37%
Pharmaceuticals	Pharmaceuticals, 5, 2.81% Pharmaceuticals 5 publications, 2.81%
Angewandte Chemie - International Edition	Angewandte Chemie - International Edition, 4, 2.25% Angewandte Chemie - International Edition 4 publications, 2.25%
Scientific Reports	Scientific Reports, 4, 2.25% Scientific Reports 4 publications, 2.25%
Pharmaceutics	Pharmaceutics, 4, 2.25% Pharmaceutics 4 publications, 2.25%
European Journal of Medicinal Chemistry	European Journal of Medicinal Chemistry, 4, 2.25% European Journal of Medicinal Chemistry 4 publications, 2.25%
Angewandte Chemie	Angewandte Chemie, 4, 2.25% Angewandte Chemie 4 publications, 2.25%
Molecules	Molecules, 3, 1.69% Molecules 3 publications, 1.69%
Antimicrobial Agents and Chemotherapy	Antimicrobial Agents and Chemotherapy, 3, 1.69% Antimicrobial Agents and Chemotherapy 3 publications, 1.69%
Russian Chemical Bulletin	Russian Chemical Bulletin, 2, 1.12% Russian Chemical Bulletin 2 publications, 1.12%
AAPS Open	AAPS Open, 2, 1.12% AAPS Open 2 publications, 1.12%
Bioorganic and Medicinal Chemistry	Bioorganic and Medicinal Chemistry, 2, 1.12% Bioorganic and Medicinal Chemistry 2 publications, 1.12%
Analytica Chimica Acta	Analytica Chimica Acta, 2, 1.12% Analytica Chimica Acta 2 publications, 1.12%
Bioorganic and Medicinal Chemistry Letters	Bioorganic and Medicinal Chemistry Letters, 2, 1.12% Bioorganic and Medicinal Chemistry Letters 2 publications, 1.12%
ChemMedChem	ChemMedChem, 2, 1.12% ChemMedChem 2 publications, 1.12%
Journal of the American Chemical Society	Journal of the American Chemical Society, 2, 1.12% Journal of the American Chemical Society 2 publications, 1.12%
Journal of Organic Chemistry	Journal of Organic Chemistry, 2, 1.12% Journal of Organic Chemistry 2 publications, 1.12%
Chemical Science	Chemical Science, 2, 1.12% Chemical Science 2 publications, 1.12%
Organic and Biomolecular Chemistry	Organic and Biomolecular Chemistry, 2, 1.12% Organic and Biomolecular Chemistry 2 publications, 1.12%
Chemical Communications	Chemical Communications, 2, 1.12% Chemical Communications 2 publications, 1.12%
Infection and Drug Resistance	Infection and Drug Resistance, 2, 1.12% Infection and Drug Resistance 2 publications, 1.12%
Beilstein Journal of Organic Chemistry	Beilstein Journal of Organic Chemistry, 1, 0.56% Beilstein Journal of Organic Chemistry 1 publication, 0.56%
Current Organic Chemistry	Current Organic Chemistry, 1, 0.56% Current Organic Chemistry 1 publication, 0.56%
Chemical Papers	Chemical Papers, 1, 0.56% Chemical Papers 1 publication, 0.56%
Journal of Water and Health	Journal of Water and Health, 1, 0.56% Journal of Water and Health 1 publication, 0.56%
Biochemical Society Transactions	Biochemical Society Transactions, 1, 0.56% Biochemical Society Transactions 1 publication, 0.56%
Infectious Diseases Research and Treatment	Infectious Diseases Research and Treatment, 1, 0.56% Infectious Diseases Research and Treatment 1 publication, 0.56%
	1 2 3 4 5 6 7 8

Citations by publishers

	5 10 15 20 25 30 35
American Chemical Society (ACS)	American Chemical Society (ACS), 31, 17.42% American Chemical Society (ACS) 31 publications, 17.42%
Elsevier	Elsevier, 27, 15.17% Elsevier 27 publications, 15.17%
Multidisciplinary Digital Publishing Institute (MDPI)	Multidisciplinary Digital Publishing Institute (MDPI), 24, 13.48% Multidisciplinary Digital Publishing Institute (MDPI) 24 publications, 13.48%
Wiley	Wiley, 22, 12.36% Wiley 22 publications, 12.36%
Springer Nature	Springer Nature, 17, 9.55% Springer Nature 17 publications, 9.55%
Royal Society of Chemistry (RSC)	Royal Society of Chemistry (RSC), 11, 6.18% Royal Society of Chemistry (RSC) 11 publications, 6.18%
Frontiers Media S.A.	Frontiers Media S.A., 3, 1.69% Frontiers Media S.A. 3 publications, 1.69%
American Society for Microbiology	American Society for Microbiology, 3, 1.69% American Society for Microbiology 3 publications, 1.69%
SAGE	SAGE, 2, 1.12% SAGE 2 publications, 1.12%
Taylor & Francis	Taylor & Francis, 2, 1.12% Taylor & Francis 2 publications, 1.12%
Dove Medical Press	Dove Medical Press, 2, 1.12% Dove Medical Press 2 publications, 1.12%
Beilstein-Institut	Beilstein-Institut, 1, 0.56% Beilstein-Institut 1 publication, 0.56%
Bentham Science	Bentham Science, 1, 0.56% Bentham Science 1 publication, 0.56%
IWA Publishing	IWA Publishing, 1, 0.56% IWA Publishing 1 publication, 0.56%
Portland Press	Portland Press, 1, 0.56% Portland Press 1 publication, 0.56%
Wolters Kluwer Health	Wolters Kluwer Health, 1, 0.56% Wolters Kluwer Health 1 publication, 0.56%
American Society for Biochemistry and Molecular Biology	American Society for Biochemistry and Molecular Biology, 1, 0.56% American Society for Biochemistry and Molecular Biology 1 publication, 0.56%
eLife Sciences Publications	eLife Sciences Publications, 1, 0.56% eLife Sciences Publications 1 publication, 0.56%
Pleiades Publishing	Pleiades Publishing, 1, 0.56% Pleiades Publishing 1 publication, 0.56%
Oxford University Press	Oxford University Press, 1, 0.56% Oxford University Press 1 publication, 0.56%
American Association for the Advancement of Science (AAAS)	American Association for the Advancement of Science (AAAS), 1, 0.56% American Association for the Advancement of Science (AAAS) 1 publication, 0.56%
Publishing House OKI	Publishing House OKI, 1, 0.56% Publishing House OKI 1 publication, 0.56%
Proceedings of the National Academy of Sciences (PNAS)	Proceedings of the National Academy of Sciences (PNAS), 1, 0.56% Proceedings of the National Academy of Sciences (PNAS) 1 publication, 0.56%
	5 10 15 20 25 30 35

We do not take into account publications that without a DOI.
Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
Statistics recalculated weekly.

{"yearsCitations":{"type":"bar","data":{"show":true,"labels":[2018,2019,2020,2021,2022,2023,2024],"ids":[0,0,0,0,0,0,0],"codes":[0,0,0,0,0,0,0],"imageUrls":["","","","","","",""],"datasets":[{"label":"Citations number","data":[7,24,22,46,32,36,11],"backgroundColor":["#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6"],"percentage":["3.93","13.48","12.36","25.84","17.98","20.22","6.18"],"barThickness":null}]},"options":{"indexAxis":"x","maintainAspectRatio":true,"scales":{"y":{"ticks":{"precision":0,"autoSkip":false,"font":{"family":"Montserrat"},"color":"#000000"}},"x":{"ticks":{"stepSize":1,"precision":0,"font":{"family":"Montserrat"},"color":"#000000"}}},"plugins":{"legend":{"position":"top","labels":{"font":{"family":"Montserrat"},"color":"#000000"}},"title":{"display":true,"text":"Citations per year","font":{"size":24,"family":"Montserrat","weight":600},"color":"#000000"}}}},"journals":{"type":"bar","data":{"show":true,"labels":["ACS Infectious Diseases","Journal of Medicinal Chemistry","Antibiotics","Pharmaceuticals","Angewandte Chemie - International Edition","Scientific Reports","Pharmaceutics","European Journal of Medicinal Chemistry","Angewandte Chemie","Molecules","Antimicrobial Agents and Chemotherapy","Russian Chemical Bulletin","AAPS Open","Bioorganic and Medicinal Chemistry","Analytica Chimica Acta","Bioorganic and Medicinal Chemistry Letters","ChemMedChem","Journal of the American Chemical Society","Journal of Organic Chemistry","Chemical Science","Organic and Biomolecular Chemistry","Chemical Communications","Infection and Drug Resistance","Beilstein Journal of Organic Chemistry","Current Organic Chemistry","Chemical Papers","Journal of Water and Health","Biochemical Society Transactions","Infectious Diseases Research and Treatment"],"ids":[7781,3673,1488,1203,19215,13767,4502,8171,25450,1770,17567,10918,26780,1162,19094,8828,1430,4813,8697,9646,541,9073,12706,21928,16175,4048,6964,10198,25323],"codes":[0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0],"imageUrls":["\/storage\/images\/resized\/iLiQsFqFaSEx6chlGQ5fbAwF6VYU3WWa08hkss0g_medium.webp","\/storage\/images\/resized\/iLiQsFqFaSEx6chlGQ5fbAwF6VYU3WWa08hkss0g_medium.webp","\/storage\/images\/resized\/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_medium.webp","\/storage\/images\/resized\/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_medium.webp","\/storage\/images\/resized\/bRyGpdm98BkAUYiK1YFNpl5Z7hPu6Gd87gbIeuG3_medium.webp","\/storage\/images\/resized\/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_medium.webp","\/storage\/images\/resized\/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_medium.webp","\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp","\/storage\/images\/resized\/bRyGpdm98BkAUYiK1YFNpl5Z7hPu6Gd87gbIeuG3_medium.webp","\/storage\/images\/resized\/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_medium.webp","\/storage\/images\/resized\/VPE7q24PXoHr5SS2SqfEgxccSMUxWLfZINOX60uo_medium.webp","\/storage\/images\/resized\/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_medium.webp","\/storage\/images\/resized\/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_medium.webp","\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp","\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp","\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp","\/storage\/images\/resized\/bRyGpdm98BkAUYiK1YFNpl5Z7hPu6Gd87gbIeuG3_medium.webp","\/storage\/images\/resized\/iLiQsFqFaSEx6chlGQ5fbAwF6VYU3WWa08hkss0g_medium.webp","\/storage\/images\/resized\/iLiQsFqFaSEx6chlGQ5fbAwF6VYU3WWa08hkss0g_medium.webp","\/storage\/images\/resized\/leiAYcRDGTSl5B1eCnwpSGqmDEUEfDPPoYisFGhT_medium.webp","\/storage\/images\/resized\/leiAYcRDGTSl5B1eCnwpSGqmDEUEfDPPoYisFGhT_medium.webp","\/storage\/images\/resized\/leiAYcRDGTSl5B1eCnwpSGqmDEUEfDPPoYisFGhT_medium.webp","\/storage\/images\/resized\/wVWp6zaxUsMdR03dYMdOZoesUrVGtNMWkHKByIvT_medium.webp","\/storage\/images\/resized\/ex6KJoZujZOZFZh7jGfeHauiftuB3CI7iwJVFRDg_medium.webp","\/storage\/images\/resized\/doUaFUZdxUEQjLi1TwZjGHi8HXYNWWSk04dSC6Xh_medium.webp","\/storage\/images\/resized\/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_medium.webp","\/storage\/images\/resized\/uGx6c1W3cHqbKXWIuICsBj3302lg4GbPWL7ng21d_medium.webp","\/storage\/images\/resized\/nUqNrP9GnM1t0BrAIXp1LBodjU8aIJ2Fk4pLfGhZ_medium.webp","\/storage\/images\/resized\/ruydfaB80LDjlkYqsfOeUAZohOIODyq7bQzis5O7_medium.webp"],"datasets":[{"label":"","data":[8,7,6,5,4,4,4,4,4,3,3,2,2,2,2,2,2,2,2,2,2,2,2,1,1,1,1,1,1],"backgroundColor":["#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6"],"percentage":[4.49,3.93,3.37,2.81,2.25,2.25,2.25,2.25,2.25,1.69,1.69,1.12,1.12,1.12,1.12,1.12,1.12,1.12,1.12,1.12,1.12,1.12,1.12,0.56,0.56,0.56,0.56,0.56,0.56],"barThickness":13}]},"options":{"indexAxis":"y","maintainAspectRatio":false,"scales":{"y":{"ticks":{"precision":0,"autoSkip":false,"font":{"family":"Montserrat"},"color":"#000000"}},"x":{"ticks":{"stepSize":null,"precision":0,"font":{"family":"Montserrat"},"color":"#000000"}}},"plugins":{"legend":{"position":"top","labels":{"font":{"family":"Montserrat"},"color":"#000000"}},"title":{"display":true,"text":"Journals","font":{"size":24,"family":"Montserrat","weight":600},"color":"#000000"}}}},"publishers":{"type":"bar","data":{"show":true,"labels":["American Chemical Society (ACS)","Elsevier","Multidisciplinary Digital Publishing Institute (MDPI)","Wiley","Springer Nature","Royal Society of Chemistry (RSC)","Frontiers Media S.A.","American Society for Microbiology","SAGE","Taylor & Francis","Dove Medical Press","Beilstein-Institut","Bentham Science","IWA Publishing","Portland Press","Wolters Kluwer Health","American Society for Biochemistry and Molecular Biology","eLife Sciences Publications","Pleiades Publishing","Oxford University Press","American Association for the Advancement of Science (AAAS)","Publishing House OKI","Proceedings of the National Academy of Sciences (PNAS)"],"ids":[40,17,202,11,8,123,208,142,31,18,417,6139,39,1283,801,32,2090,6627,101,19,189,9233,162],"codes":[0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0],"imageUrls":["\/storage\/images\/resized\/iLiQsFqFaSEx6chlGQ5fbAwF6VYU3WWa08hkss0g_medium.webp","\/storage\/images\/resized\/GDnYOu1UpMMfMMRV6Aqle4H0YLLsraeD9IP9qScG_medium.webp","\/storage\/images\/resized\/MjH1ITP7lMYGxeqUZfkt2BnVLgjkk413jwBV97XX_medium.webp","\/storage\/images\/resized\/bRyGpdm98BkAUYiK1YFNpl5Z7hPu6Gd87gbIeuG3_medium.webp","\/storage\/images\/resized\/voXLqlsvTwv5p3iMQ8Dhs95nqB4AXOG7Taj7G4ra_medium.webp","\/storage\/images\/resized\/leiAYcRDGTSl5B1eCnwpSGqmDEUEfDPPoYisFGhT_medium.webp","\/storage\/images\/resized\/4QWA67eqfcfyOiA8Wk7YnqroHFqQbTsmDJUYTCTg_medium.webp","\/storage\/images\/resized\/VPE7q24PXoHr5SS2SqfEgxccSMUxWLfZINOX60uo_medium.webp","\/storage\/images\/resized\/ruydfaB80LDjlkYqsfOeUAZohOIODyq7bQzis5O7_medium.webp","\/storage\/images\/resized\/5YZtvLvkPZuc2JHOaZsjCvGSHFCuC3drUwN3YAc5_medium.webp","\/storage\/images\/resized\/wVWp6zaxUsMdR03dYMdOZoesUrVGtNMWkHKByIvT_medium.webp","\/storage\/images\/resized\/ex6KJoZujZOZFZh7jGfeHauiftuB3CI7iwJVFRDg_medium.webp","\/storage\/images\/resized\/doUaFUZdxUEQjLi1TwZjGHi8HXYNWWSk04dSC6Xh_medium.webp","\/storage\/images\/resized\/uGx6c1W3cHqbKXWIuICsBj3302lg4GbPWL7ng21d_medium.webp","\/storage\/images\/resized\/nUqNrP9GnM1t0BrAIXp1LBodjU8aIJ2Fk4pLfGhZ_medium.webp","\/storage\/images\/resized\/6QE8LXWrLpkoy5A2te6hw7who46GeCoTYIstuoAz_medium.webp","\/storage\/images\/resized\/OuA6WPZekwEiUM99mP2pSqj4yHPxHezM6xgLhAjO_medium.webp","\/storage\/images\/resized\/eIZgkq1MRZyJ3hBkdupnUUv7wgB6zCl9D99SlPN5_medium.webp","\/storage\/images\/resized\/oZgeErrVFhuDksyqFURLvYS1wtVSBWczh001igGo_medium.webp","\/storage\/images\/resized\/yNSijlgQghQF53VZuyFLA30CKDe4j3HK74Vtpnxa_medium.webp","\/storage\/images\/resized\/s10mcsCV4OAUg9O2KrqOquQC0PhyLMI8hUUkuflM_medium.webp","\/storage\/images\/resized\/0pyMnw6hqXp4LxgRirQNJzhuW46UNQvBNr64G5dP_medium.webp","\/storage\/images\/resized\/mxFdPe9qujsfvfYfcN0QOclAiYORFb0xrRlwV8gs_medium.webp"],"datasets":[{"label":"","data":[31,27,24,22,17,11,3,3,2,2,2,1,1,1,1,1,1,1,1,1,1,1,1],"backgroundColor":["#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6","#3B82F6"],"percentage":[17.42,15.17,13.48,12.36,9.55,6.18,1.69,1.69,1.12,1.12,1.12,0.56,0.56,0.56,0.56,0.56,0.56,0.56,0.56,0.56,0.56,0.56,0.56],"barThickness":13}]},"options":{"indexAxis":"y","maintainAspectRatio":false,"scales":{"y":{"ticks":{"precision":0,"autoSkip":false,"font":{"family":"Montserrat"},"color":"#000000"}},"x":{"ticks":{"stepSize":null,"precision":0,"font":{"family":"Montserrat"},"color":"#000000"}}},"plugins":{"legend":{"position":"top","labels":{"font":{"family":"Montserrat"},"color":"#000000"}},"title":{"display":true,"text":"Publishers","font":{"size":24,"family":"Montserrat","weight":600},"color":"#000000"}}}}}

Metrics

Cite this

GOST |

Cite this

GOST Copy

Blaskovich M. A. et al. Developments in Glycopeptide Antibiotics // ACS Infectious Diseases. 2018. Vol. 4. No. 5. pp. 715-735.

GOST all authors (up to 50) Copy

Blaskovich M. A., Hansford K. A., Butler M. D., Jia Z., Mark A. E., Cooper M. A. Developments in Glycopeptide Antibiotics // ACS Infectious Diseases. 2018. Vol. 4. No. 5. pp. 715-735.

RIS |

Cite this

RIS Copy

TY - JOUR

DO - 10.1021/acsinfecdis.7b00258

UR - https://doi.org/10.1021%2Facsinfecdis.7b00258

TI - Developments in Glycopeptide Antibiotics

T2 - ACS Infectious Diseases

AU - Blaskovich, Mark AT

AU - Hansford, Karl A

AU - Butler, Mark D.

AU - Mark, Alan E.

AU - Cooper, Matthew A.

AU - Jia, Zhiguang

PY - 2018

DA - 2018/01/24 00:00:00

PB - American Chemical Society (ACS)

SP - 715-735

IS - 5

VL - 4

PMID - 29363950

SN - 2373-8227

ER -

BibTex |

Cite this

BibTex Copy

@article{2018_Blaskovich,

author = {Mark AT Blaskovich and Karl A Hansford and Mark D. Butler and Alan E. Mark and Matthew A. Cooper and Zhiguang Jia},

title = {Developments in Glycopeptide Antibiotics},

journal = {ACS Infectious Diseases},

year = {2018},

volume = {4},

publisher = {American Chemical Society (ACS)},

month = {jan},

url = {https://doi.org/10.1021%2Facsinfecdis.7b00258},

number = {5},

pages = {715--735},

doi = {10.1021/acsinfecdis.7b00258}

}

MLA

Cite this

MLA Copy

Blaskovich, Mark AT, et al. “Developments in Glycopeptide Antibiotics.” ACS Infectious Diseases, vol. 4, no. 5, Jan. 2018, pp. 715-735. https://doi.org/10.1021%2Facsinfecdis.7b00258.

Found error?

Publisher

American Chemical Society (ACS)

Journal

ACS Infectious Diseases

Quartile SCImago

Quartile WOS

Impact factor

5.3

ISSN

23738227 (Electronic)